Qubit-Wise Architecture Search Method for Variational Quantum Circuits

Considering the noise level limit, one crucial aspect for quantum machine learning is to design a high-performing variational quantum circuit architecture with small number of quantum gates. As the classical neural architecture search (NAS), quantum architecture search methods (QAS) employ methods like reinforcement learning, evolutionary algorithms and supernet optimiza-tion to improve the search efficiency. In this paper, we propose a novel qubit-wise architec-ture search (QWAS) method, which progres-sively search one-qubit configuration per stage, and combine with Monte Carlo Tree Search al-gorithm to find good quantum architectures by partitioning the search space into several good and bad subregions. The numerical experimental results indicate that our proposed method can balance the exploration and exploitation of cir-cuit performance and size in some real-world tasks, such as MNIST, Fashion and MOSI. As far as we know, QWAS achieves the state-of-art re-sults of all tasks in the terms of accuracy and circuit size

Towards Constituting Mathematical Structures for Learning to Optimize

Learning to Optimize (L2O), a technique that utilizes machine learning to learn an optimization algorithm automatically from data, has gained arising attention in recent years. A generic L2O approach parameterizes the iterative update rule and learns the update direction as a black-box network. While the generic approach is widely applicable, the learned model can overfit and may not generalize well to out-of-distribution test sets. In this paper, we derive the basic mathematical conditions that successful update rules commonly satisfy. Consequently, we propose a novel L2O model with a mathematics-inspired structure that is broadly applicable and generalized well to out-of-distribution problems. Numerical simulations validate our theoretical findings and demonstrate the superior empirical performance of the proposed L2O model.Comment: ICML 202

A perspective on meta-boundaries

The judicious design of electromagnetic boundary provides a crucial route to control light-matter interactions, and it is thus fundamental to basic science and practical applications. General design approaches rely on the manipulation of bulk properties of superstrate or substrate and on the modification of boundary geometries. Due to the recent advent of metasurfaces and low-dimensional materials, the boundary can be flexibly featured with a surface conductivity, which can be rather complex but provide an extra degree of freedom to regulate the propagation of light. In this perspective, we denote the boundary with a non-zero surface conductivity as the meta-boundary. The meta-boundaries are categorized into four types, namely isotropic, anisotropic, biisotropic and bianisotropic meta-boundaries, according to the electromagnetic boundary conditions. Accordingly, the latest development for these four kinds of meta-boundaries are reviewed. Finally, an outlook on the research tendency of meta-boundaries is provided, particularly on the manipulation of light-matter interactions by simultaneously exploiting meta-boundaries and metamaterials

Biogenesis aberration: One of the mechanisms of thrombocytopenia in COVID-19

Background: The pathogenesis of COVID-19, including thrombocytopenia, has not been fully clarified. The lungs are a major organ of platelet production and thrombocytopenia induced by severe COVID-19 was proposed.Methods: the change of platelet level was analysed with clinical parameters in 95 hospitalized COVID-19 patients in Wuhan Third Hospital. The production of platelets in the lungs was explored in an ARDS rat model.Results: The level of platelets was negatively correlated with disease severity and was recovered with disease improvement. The non-survivors were accompanied by lower levels of platelet. The odds ratio (OR) of the valley level of the platelet count (PLTlow) was greater than 1, suggesting that PLTlow could be a death exposure factor. The platelet/lymphocyte ratio (PLR) was positively associated with severity of COVID-19, and the platelet/lymphocyte ratio threshold of 248.5 was best correlated with death risk (sensitivity 0.641 and specificity 0.815). To demonstrate the possible biogenesis aberration of platelet in lungs, an LPS-induced ARDS rat model was applied. Lower level of platelet in peripheral and less production of platelet from lungs in ARDS were demonstrated. Though megakaryocyte (MK) number in ARDS lungs is higher than controls, the immature platelet fraction (IPF) in postpulmonary blood is still at the same level as prepulmonary in ARDS rat, indicating that ARDS rats generated fewer platelets in lungs.Conclusion: Our data suggested that COVID-19-induced severe lung inflammation may impair platelet production in the lung. Thrombocytopenia may be mainly caused by platelet consumption for multiorgan thrombosis; however, biogenesis aberration of platelet in the lung induced by diffuse interstitial pulmonary damage cannot be ruled out

Surgical treatment of patellar dislocation: A network meta-analysis of randomized control trials and cohort studies

BackgroundCurrently, there are many surgical options for patellar dislocation. The purpose of this study is to perform a network meta-analysis of the randomized controlled trials (RCTs) and cohort studies to determine the better treatment.MethodWe searched the Pubmed, Embase, Cochrane Central Register of Controlled Trials, Web of Science, clinicaltrials.gov and who.int/trialsearch. Clinical outcomes included Kujala score, Lysholm score, International Knee Documentation Committee (IKDC) score, redislocation or recurrent instability. We conducted pairwise meta-analysis and network meta-analysis respectively using the frequentist model to compare the clinical outcomes.ResultsThere were 10 RCTs and 2 cohort studies with a total of 774 patients included in our study. In network meta-analysis, double-bundle medial patellofemoral ligament reconstruction (DB-MPFLR) achieved good results on functional scores. According to the surface under the cumulative ranking (SUCRA), DB-MPFLR had the highest probabilities of their protective effects on outcomes of Kujala score (SUCRA 96.5 %), IKDC score (SUCRA 100.0%) and redislocation (SUCRA 67.8%). However, DB-MPFLR (SUCRA 84.6%) comes second to SB-MPFLR (SUCRA 90.4%) in Lyshlom score. It is (SUCRA 70%) also inferior to vastus medialis plasty (VM-plasty) (SUCRA 81.9%) in preventing Recurrent instability. The results of subgroup analysis were similar.ConclusionOur study demonstrated that MPFLR showed better functional scores than other surgical options

Combining modern tracking data and historical records improves understanding of the summer habitats of the Eastern Lesser White‐fronted Goose Anser erythropus

Abstract: The Lesser White‐fronted Goose (Anser erythropus), smallest of the “gray” geese, is listed as Vulnerable on the IUCN Red List and protected in all range states. There are three populations, with the least studied being the Eastern population, shared between Russia and China. The extreme remoteness of breeding enclaves makes them largely inaccessible to researchers. As a substitute for visitation, remotely tracking birds from wintering grounds allows exploration of their summer range. Over a period of three years, and using highly accurate GPS tracking devices, eleven individuals of A. erythropus were tracked from the key wintering site of China, to summering, and staging sites in northeastern Russia. Data obtained from that tracking, bolstered by ground survey and literature records, were used to model the summer distribution of A. erythropus. Although earlier literature describes a patchy summer range, the model suggests a contiguous summer habitat range is possible, although observations to date cannot confirm A. erythropus is present throughout the modeled range. The most suitable habitats are located along the coasts of the Laptev Sea, primarily the Lena Delta, in the Yana‐Kolyma Lowland, and smaller lowlands of Chukotka with narrow riparian extensions upstream along major rivers such as the Lena, Indigirka, and Kolyma. The probability of A. erythropus presence is related to areas with altitude less than 500 m with abundant wetlands, especially riparian habitat, and a climate with precipitation of the warmest quarter around 55 mm and mean temperature around 14°C during June‐August. Human disturbance also affects site suitability, with a gradual decrease in species presence starting around 160 km from human settlements. Remote tracking of animal species can bridge the knowledge gap required for robust estimation of species distribution patterns in remote areas. Better knowledge of species' distribution is important in understanding the large‐scale ecological consequences of rapid global change and establishing conservation management strategies

Cabozantinib in combination with immune checkpoint inhibitors for renal cell carcinoma: a systematic review and meta-analysis

ContextCabozantinib combined with immune checkpoint inhibitors (ICIs) has brought a new therapeutic effect for the medical treatment of renal cell carcinoma (RCC).ObjectivesWe performed a meta-analysis of randomized controlled trials and single-arm trials to evaluate the efficacy and safety of cabozantinib plus ICIs in RCC.MethodsWe extracted data from PubMed, Cochrane, Medline and Embase databases, and rated literature quality through Cochrane risk of bias tool and MINORS. RevMan5.3 software was used to analyze the results of randomized controlled trials and single-arm trials.ResultsA total of 7 studies were included. Treatment with cabozantinib plus ICIs improved PFS [HR 0.75, (95%CI: 0.52, 1.08), p = 0.12] and the OS [HR 0.80, (95%CI: 0.60, 1.07), p = 0.13] in randomized controlled trials. Meanwhile, the result of the ORR in randomized controlled trials was [risk ratio (RR) 1.37, (95%CI: 1.21, 1.54), p < 0.00001] and in single-arm trials was [risk difference (RD) 0.49, (95%CI: 0.26, 0.71), p < 0.0001].ConclusionCabozantinib plus ICIs prolonged the PFS and OS, and improved ORR in patients with RCC. Our recommendation is to use cabozantinib plus ICIs to treat advanced RCC, and to continuous monitor and manage the drug-related adverse events.Systematic Review Registration:identifier CRD42023455878